StockData
NUMDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Nu-Med Plus, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026

Market cap
$601.55K
P/E (TTM)
–
Dividend yield
–

Ownership

Who owns Nu-Med Plus's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Fred Tejada8,131,2509.70%13D (active)Jul 8, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Fred TejadaSVP and Chief Geologist, Director, 10% owner16,381,25019.61%Aug 25, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Fred Tejada
SVP and Chief Geologist, Director, 10% owner
Jul 8, 2026Award+1,000,000––1,000,000
Fred Tejada
SVP and Chief Geologist, Director, 10% owner
Jul 8, 2026Other+16,381,250––16,381,250
William C. Hayde
Chief Executive Officer, Director
Nov 7, 2023Award+1,000,000$0.02$20.00K1,000,000
Jeffrey Lynn Robins
Director
Nov 7, 2023Award+200,000$0.02$4.00K5,200,000
Craig Morrison
Vice President of Technology, Director
Aug 5, 2016Other−2,000,000––2,000,000
Brett J. Earl
VP of Medical Marketing, Director
Apr 23, 2015Award+800,000––1,000,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.